GLP-1 Coverage in Employer Plans Could Nearly Double in 2024

Accolade, a Personalized Healthcare company, has released findings from a recent employer survey on the sentiment and adoption of GLP-1 medications. The survey revealed that while 81% of HR decision-makers believe their employees would be interested in GLP-1 medications, only 25% currently offer coverage for them.

GLP-1 medications, originally designed for diabetes management, have gained significant popularity as an effective drug for weight loss and obesity. HR decision-makers recognize the benefits of GLP-1 medications in controlling blood sugar, promoting weight loss, improving blood pressure, and reducing the risk of heart disease.

The survey identified two main barriers to incorporating GLP-1 medications into employer plans: lack of trusted information and perceived high costs. Nearly half of the respondents cited a lack of information about other uses of the drug as a reason for not covering GLP-1s. They expressed a preference for obtaining information from doctors and medical organizations or publications. Additionally, 38% of HR decision-makers mentioned the costs associated with GLP-1 medications as a potential barrier.

Despite these obstacles, the survey indicated that GLP-1 coverage is seen as an attractive and desired benefit by most HR decision-makers. A significant majority (81%) believe that adding GLP-1 medications to their benefits package would enhance employees’ health and perception of healthcare benefits.

Employers who already cover GLP-1s (25%) expressed their intention to continue offering coverage, with 99% planning to do so. These employers reported a strong financial impact from adding GLP-1 medications, but also noted an increase in enrollment after their inclusion.

Accolade recommends that HR decision-makers approach the decision of offering GLP-1 coverage with ample research from physicians and medical organizations. They emphasize a comprehensive care perspective that considers the total cost and beneficial outcomes of well-managed employee health.

The survey, conducted by Savanta, involved 500 HR decision-makers from medium and large businesses across various industries in the United States.

Accolade, known for providing exceptional healthcare experiences, combines virtual primary care, mental health support, expert medical opinion, and care navigation services. Their offerings are designed to address population health needs, improve outcomes, and reduce costs while ensuring access and continuity of care.

For more information on Accolade and their services, visit accolade.com. Stay updated by following them on LinkedIn, Twitter, Instagram, and Facebook.

Source: PRNewswire